Clinical trial · Observational
Metabolic and Endocrine Status in Women With Prior Preterm Birth
Metabolic and Endocrine Status in Women With Prior Preterm Birth. A Cross Sectional, Case- Control Study
NCT01355536CI-TRIAL-00004872completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The prevalence of preterm birth is rising in most western countries. The causes of preterm birth is not fully understood and seem to be multifactorial. The endocrine and metabolic aspects are scarcely investigated.The main purpose of this study is to test the hypothesis that endocrine and metabolic factors associate to preterm births.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Diabetes Mellitus | — | UNRESOLVED | — |
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
| Preterm Birth | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Preterm birth group
- description
- Women with prior preterm birth
- label
- Term birth group
- description
- Women with prior term birth
Primary outcomes (2)
- measure
- The prevalence of PCOS
- timeFrame
- one week after enrollment.
- description
- The prevalence of PCOS will be assessed in both study groups and the difference between the groups will be reported.
- measure
- The prevalence of Diabetes Mellitus
- timeFrame
- one week after enrollment
- description
- The prevalence of Diabetes Mellitus will be assessed in both study groups and the difference between the groups will be reported.
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * One or more preterm birth in the given period of time * Having Namsos Hospital as their local Hospital during pregnancy Exclusion Criteria: * Moved from the region of Mid- Norway at the time of the study * Lack of communication skills in Norwegian or English * Ongoing pregnancy * Ongoing breastfeeding
References
Publications (2)
- DERIVEDEilertsen TB, Vanky E, Carlsen SM. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod. 2012 Aug;27(8):2494-502. doi: 10.1093/humrep/des213. Epub 2012 Jun 12. PMID 22693172
- DERIVEDEilertsen TB, Vanky E, Carlsen SM. Increased prevalence of diabetes and polycystic ovary syndrome in women with a history of preterm birth: a case-control study. BJOG. 2012 Feb;119(3):266-75. doi: 10.1111/j.1471-0528.2011.03206.x. Epub 2011 Dec 13. PMID 22168920